Prevention of iatrogenic acute narrow-angle glaucoma.
The pathophysiology of glaucoma is reviewed, and the risks of pharmacologic pupillary dilation are discussed. A simple transillumination screening test for identifying patients in whom mydriasis presents a risk is described.